Brookline, MA, United States of America

Ken Yamada

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 6.8

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Cambridge, MA (US) (2014)
  • Brookline, MA (US) (2013 - 2022)
  • Boston, MA (US) (2012 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: Ken Yamada: Innovator in Cardiovascular Therapeutics

Introduction

Ken Yamada, an accomplished inventor based in Brookline, MA, has made significant contributions to the field of pharmaceutical innovations. With a total of eight patents to his name, Yamada's work primarily focuses on the development of compounds aimed at treating cardiovascular conditions, particularly arrhythmias. His dedication to advancing medical science exemplifies the spirit of innovation that drives the pharmaceutical industry.

Latest Patents

Among his latest contributions, Yamada has been instrumental in the invention of naphthyridinone derivatives aimed at treating arrhythmia. His recent patent details the provision of compounds with the formula (I) or pharmaceutically acceptable salts thereof, along with a method for manufacturing these compounds. The invention showcases therapeutic uses that could revolutionize treatment strategies for heart rhythm disorders. Additionally, it includes a combination of pharmacologically active agents and a pharmaceutical composition, reflecting his commitment to improving healthcare outcomes.

Career Highlights

Yamada is currently employed at Novartis AG, a company recognized for its dedication to providing innovative healthcare solutions. His role involves extensive research and development, allowing him to partake in pivotal projects that push the boundaries of medical science. Throughout his career, Yamada has been at the forefront of drug development, with a focus on creating effective treatments that address pressing health challenges in cardiovascular care.

Collaborations

Collaboration has been a cornerstone of Yamada's success in the field. He has worked alongside notable colleagues, including Kayo Yasoshima and Muneto Mogi, fostering a collaborative environment that enhances creativity and accelerates the research process. Together, they contribute to groundbreaking discoveries that hold the potential to save lives.

Conclusion

Ken Yamada's innovative spirit and dedication to advancing medical therapies make him a noteworthy figure in the pharmaceutical industry. With several patents to his credit and a strong collaborative network, Yamada continues to have a lasting impact on the treatment of cardiovascular diseases. His work not only represents individual achievement but also signifies the collective effort towards improving health and well-being on a global scale.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…